SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Techniclone (TCLN) -- Ignore unavailable to you. Want to Upgrade?


To: Maurice Winn who wrote (2417)8/13/1998 8:11:00 PM
From: EZLibra  Read Replies (2) | Respond to of 3702
 
If golfdad doesn't wish it then I won't do it. Furthermore it's not like I'm a frequent poster at CLTR (once) or IDPH (never). It does bother me that each company has been pulling the NZ wool over their shareholders eyes as regards TCLN. The fact that they never mention Techniclone as a perceived competitor in their 10K's is a couple of lawsuits waiting to happen, IMO.

Yet even V1 is thinking a cocktail is the wave to catch for future NHL treatment. What people are missing, IMO, is that the cocktail is likely to be chemo with a MOaB. Chemo successfully treats 60-70% of NHL, Oncolym reaches 80%. Either leaves the imune system intact. That doesn't leave much NHL to treat. Will HMO's pay 10,000 for chemo plus 10,000 for Oncolym plus 10,000 for Rituxan or Y2B8 and a redundant 10,000 for Bexxar? We all focus too much on MOaBs. Who is the dominant player in NHL chemo therapy?

I understand your combo proposition and agree. Will the real HMO world?



To: Maurice Winn who wrote (2417)8/13/1998 8:36:00 PM
From: john dixon  Read Replies (1) | Respond to of 3702
 
Maurice, correct me if I am wrong and I am sure you will, but the last time the PUBLIC had a chance to invest in tcln was 1983 or there about. Buying stock in this co. in the open market does not put money in tcln's coffers.

john

PS: At least my last post woke this thread up! Alys, where are youuu?



To: Maurice Winn who wrote (2417)8/13/1998 9:20:00 PM
From: Terry D.  Respond to of 3702
 
Maurice
I would love TCLN to go through the sky. As you stated, it would be killing two birds with one stone. Technoclone is a personal thing for me. If I make money that's great because it means they accomplished what I was looking for when I invested. If I don't make money then all the research and hype was for nothing. I just wish I could have gotten on board during their IPO. Well, maybe not. I do recall a 1 for 100 reverse split.

Terry